Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 845.20
-31.00 (-3.54%)
Oct 21, 2026, 3:29 PM IST
Shilpa Medicare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 165,257 | 68,190 | 57,550 | 40,046 | 19,908 | 34,473 | |
Market Cap Growth | 133.96% | 18.49% | 43.71% | 101.16% | -42.25% | 26.68% |
Enterprise Value | 171,404 | 73,916 | 62,197 | 48,372 | 27,280 | 42,348 |
Last Close Price | 845.20 | 348.68 | 331.09 | 229.85 | 114.21 | 198.17 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 55.61 | 28.02 | 73.51 | 125.64 | - | 56.83 |
PS Ratio | 9.82 | 4.43 | 4.47 | 3.47 | 1.89 | 3.01 |
PB Ratio | 6.38 | 2.63 | 2.44 | 2.23 | 1.12 | 1.90 |
P/TBV Ratio | 8.72 | 3.60 | 3.20 | 3.08 | 1.54 | 2.50 |
P/OCF Ratio | 48.30 | 19.93 | 43.51 | 29.30 | 11.07 | 32.79 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 10.18 | 4.80 | 4.83 | 4.20 | 2.59 | 3.69 |
EV/EBITDA Ratio | 34.33 | 19.46 | 20.37 | 20.64 | 31.52 | 21.47 |
EV/EBIT Ratio | 45.45 | 28.12 | 31.86 | 37.46 | - | 35.17 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.26 | 0.26 | 0.25 | 0.52 | 0.45 | 0.38 |
Debt / EBITDA Ratio | 1.39 | 1.73 | 1.92 | 3.99 | 9.17 | 3.49 |
Net Debt / Equity Ratio | 0.24 | 0.24 | 0.24 | 0.50 | 0.44 | 0.36 |
Net Debt / EBITDA Ratio | 1.29 | 1.63 | 1.84 | 3.87 | 9.00 | 3.34 |
Net Debt / FCF Ratio | - | -21.74 | -5.05 | -18.94 | -16.67 | -2.90 |
Asset Turnover | - | 0.44 | 0.40 | 0.39 | 0.36 | 0.42 |
Inventory Turnover | - | 1.46 | 1.31 | 1.33 | 1.36 | 1.28 |
Quick Ratio | - | 0.84 | 0.88 | 0.72 | 0.53 | 0.81 |
Current Ratio | - | 1.31 | 1.46 | 1.26 | 0.98 | 1.45 |
Return on Equity (ROE) | - | 9.82% | 3.76% | 1.79% | -1.73% | 3.70% |
Return on Assets (ROA) | - | 4.68% | 3.81% | 2.69% | -0.12% | 2.73% |
Return on Invested Capital (ROIC) | 9.53% | 7.06% | 4.44% | 2.89% | -0.21% | 3.06% |
Return on Capital Employed (ROCE) | - | 9.20% | 7.40% | 5.40% | -0.30% | 5.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.80% | 3.57% | 1.36% | 0.80% | -1.63% | 1.76% |
FCF Yield | -0.17% | -0.42% | -1.94% | -1.20% | -2.35% | -6.58% |
Dividend Yield | 0.07% | 0.17% | 0.17% | - | - | 0.28% |
Payout Ratio | 3.95% | 4.02% | - | - | - | 14.78% |
Buyback Yield / Dilution | -0.05% | -0.37% | -12.24% | - | -3.91% | -2.46% |
Total Shareholder Return | 0.02% | -0.20% | -12.07% | - | -3.91% | -2.19% |